142 related articles for article (PubMed ID: 16432864)
21. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
[TBL] [Abstract][Full Text] [Related]
22. [The significance of dynamic detection of WT1 expression on patients of hematologic malignancy following allogeneic hematopoietic stem cell transplantation].
Jin S; Liu DH; Xu LP; Chen H; Chen YH; Qin YZ; Liu YR; Liu KY; Huang XJ
Zhonghua Nei Ke Za Zhi; 2008 Jul; 47(7):578-81. PubMed ID: 19035171
[TBL] [Abstract][Full Text] [Related]
23. Successful allogeneic bone marrow transplantation in a case with myelodysplastic syndrome which developed following Fanconi anemia.
Ikushima S; Hibi S; Todo S; Sawada T; Matsumoto Y; Iwami H; Tsunamoto K; Kasubuchi Y; Yabe M; Kato S
Bone Marrow Transplant; 1995 Oct; 16(4):621-4. PubMed ID: 8528182
[TBL] [Abstract][Full Text] [Related]
24. [Clinical course of the disease and the level of WT1 mRNA in 191 patients with acute myeloid leukemia (AML): joint research by 23 institutions in Japan].
Miyawaki S; Emi N; Mitani K; Oyashiki K; Kitamura K; Morishita T; Ogawa H; Komatsu N; Soma T; Tamaki T; Kosugi H; Ohnishi K; Mizoguchi H; Hiraoka A; Kodera Y; Ueda R; Morishima Y; Nakagawa M; Tobita T; Sugimoto K; Chiba S; Inoue N; Hamaguchi M; Koga D; Tamaki H; Naoe T; Sugiyama H; Takaku F
Rinsho Ketsueki; 2005 Dec; 46(12):1279-87. PubMed ID: 16447800
[TBL] [Abstract][Full Text] [Related]
25. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
Cilloni D; Renneville A; Hermitte F; Hills RK; Daly S; Jovanovic JV; Gottardi E; Fava M; Schnittger S; Weiss T; Izzo B; Nomdedeu J; van der Heijden A; van der Reijden BA; Jansen JH; van der Velden VH; Ommen H; Preudhomme C; Saglio G; Grimwade D
J Clin Oncol; 2009 Nov; 27(31):5195-201. PubMed ID: 19752335
[TBL] [Abstract][Full Text] [Related]
26. [Development of a new inspection diagnostic method: genetic screening of cancer].
Sugiyama H
Rinsho Byori; 2004 May; 52(5):426-9. PubMed ID: 15206129
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow transplantation for myelodysplastic syndrome--who? when? and which?
Luger S; Sacks N
Bone Marrow Transplant; 2002 Aug; 30(4):199-206. PubMed ID: 12203135
[TBL] [Abstract][Full Text] [Related]
28. High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.
Lapillonne H; Renneville A; Auvrignon A; Flamant C; Blaise A; Perot C; Lai JL; Ballerini P; Mazingue F; Fasola S; Dehée A; Bellman F; Adam M; Labopin M; Douay L; Leverger G; Preudhomme C; Landman-Parker J
J Clin Oncol; 2006 Apr; 24(10):1507-15. PubMed ID: 16575000
[TBL] [Abstract][Full Text] [Related]
29. Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry.
Locatelli F; Zecca M; Niemeyer C; Angelucci E; Arcese G; Bender-Gotze C; Bonetti F; Burdach S; Dini G; Ebell W; Friedrich W; Hasle H; Hermann J; Jacobsen N; Klingebiel T; Kremens B; Mann G; Miniero R; Pession A; Peters C; Paolucci P; Rossetti F; Schmid HJ; Stary J; Zimmermann M
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():63-8. PubMed ID: 8932802
[No Abstract] [Full Text] [Related]
30. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
Hämäläinen MM; Kairisto V; Juvonen V; Johansson J; Aurén J; Kohonen K; Remes K; Salmi TT; Helenius H; Pelliniemi TT
Eur J Haematol; 2008 Mar; 80(3):201-7. PubMed ID: 18081724
[TBL] [Abstract][Full Text] [Related]
31. Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies.
Díez-Campelo M; Pérez-Simón JA; Pérez J; Alcoceba M; Richtmon J; Vidriales B; San Miguel J
Am J Hematol; 2009 Mar; 84(3):149-52. PubMed ID: 19123459
[TBL] [Abstract][Full Text] [Related]
32. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
33. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
Sramkova L; Muzikova K; Fronkova E; Krejci O; Sedlacek P; Formankova R; Mejstrikova E; Stary J; Trka J
Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
[TBL] [Abstract][Full Text] [Related]
34. Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia.
Iwasaki T; Sugisaki C; Nagata K; Takagi K; Takagi A; Kojima T; Ito M; Nakamura S; Naoe T; Murate T
Pathol Int; 2007 Oct; 57(10):645-51. PubMed ID: 17803653
[TBL] [Abstract][Full Text] [Related]
35. Associations between the peripheral blood Wilms tumor gene 1 level and both bone marrow blast cells and the prognosis in patients with myelodysplastic syndrome.
Mashima K; Ikeda T; Toda Y; Ito S; Umino K; Minakata D; Nakano H; Morita K; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Yamamoto C; Fujiwara S; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
Leuk Lymphoma; 2019 Mar; 60(3):703-710. PubMed ID: 30188227
[TBL] [Abstract][Full Text] [Related]
36. Myelodysplastic syndrome in children and adolescents.
Niemeyer CM; Baumann I
Semin Hematol; 2008 Jan; 45(1):60-70. PubMed ID: 18179970
[TBL] [Abstract][Full Text] [Related]
37. [How to improve the results of treatment of myelodysplastic syndromes in the studies of Polish pediatric leukemia/lymphoma group].
Chybicka A; Kołecki P; Pietras W; Wójcik D; Turkiewicz D; Armata J; Eliasińska A; Kowalczyk J; Jackowska T; Klus K; Matysiak M; Krauze A; Stefańska K; Rokicka-Milewska R; Wiśniewska-Slusarz H
Wiad Lek; 1998; 51 Suppl 4():45-51. PubMed ID: 10731943
[TBL] [Abstract][Full Text] [Related]
38. Wilm's Tumor 1-guided preemptive treatment with hypomethylating agents for molecular relapse of AML and MDS after allogeneic transplantation.
Rautenberg C; Bergmann A; Pechtel S; Fischermanns C; Haas R; Germing U; Kobbe G; Schroeder T
Bone Marrow Transplant; 2021 Feb; 56(2):442-450. PubMed ID: 32873914
[TBL] [Abstract][Full Text] [Related]
39. Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide.
Hallemeier CL; Girgis MD; Blum WG; Brown RA; Khoury HJ; Devine SM; Vij R; Lin HS; DiPersio JF; Adkins DR
Biol Blood Marrow Transplant; 2006 Jul; 12(7):749-57. PubMed ID: 16785064
[TBL] [Abstract][Full Text] [Related]
40. Three consecutive related bone marrow transplants for juvenile myelomonocytic leukaemia.
Faraci M; Micalizzi C; Lanino E; Scuderi F; Morreale G; Dini G; Cappelli B; Dallorso S
Pediatr Transplant; 2005 Dec; 9(6):797-800. PubMed ID: 16269054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
